Sort by
Refine Your Search
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
procedures. The project brings together cardiovascular imaging, generative AI, and computational modeling to develop probabilistic digital twins of coronary arteries. The goal is to create patient-specific
-
20 Aug 2026 Job Information Organisation/Company Amsterdam UMC Research Field Biological sciences » Biological engineering Researcher Profile First Stage Researcher (R1) Application Deadline 1 Sep
-
The Neuropathology Research team is part of the department of Pathology at Amsterdam UMC. The team consists of neuroscientists and neuropathologists working on research into neurodegenerative diseases, including Alzheimer’s disease, frontotemporal dementia and ALS, as well as other brain...
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient
-
priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient engagement, and